Data coverage, completeness and provenance for CONTROL BIONICS LIMITED in the Stock Market API — Health Care · Medical Devices.
Source date: 2026-10-30T01:20:59. Source: yfinance. Collection time is shown separately and does not establish a trade date.
| Date | Close | Currency | Source | Adjustment basis |
|---|---|---|---|---|
| 2026-10-30 | 0.0520 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-29 | 0.0490 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-28 | 0.0490 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-27 | 0.0530 | AUD | yfinance | Split- and dividend-adjusted close |
| 2026-10-26 | 0.0530 | AUD | yfinance | Split- and dividend-adjusted close |
GET /api/v1/companies/CBL/prices · Price parameters and adjustment semantics
Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, Japan, and internationally. It offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. The company also provides the NeuroStrip, a wearable, miniaturized electromyography device; NeuroNode, a wireless, wearable sensor that allows users to access technology through bioelectric signals and spatial movements; and Cosmos Connect, a small portable control device that turns a single NeuroNode sensor into multiple outputs. In addition, it offers mounting systems under the Rehadapt brand, including wheelchair mounts, floor stands, and table stands; and switch systems comprising proximity, press, and finger switches. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is headquartered in Cremorne, Australia.
Website: https://www.controlbionics.com · Profile fields populated: 60%
Share of stored fields populated in the anchor reporting period (FY2026), primary source yfinance. Full per-field breakdown: GET /api/v1/companies/CBL/financials.
Stored values for the most recent fiscal-year periods, with per-period field counts and the primary source each period came from. Values are shown at reported scale without interpretation.
| Period | Period end | Revenue | Net income | Total assets | Total equity | Fields populated | Source |
|---|---|---|---|---|---|---|---|
| FY2026 (AUD) | 2026-06-30 | 29 | yfinance | ||||
| FY2024 (AUD) | 2024-06-30 | 31 | yfinance | ||||
| FY2023 (AUD) | 2023-06-30 | 30 | yfinance | ||||
| FY2022 (AUD) | 2022-06-30 | 31 | yfinance |
The endpoints below describe available datasets for this listing. Missing fields remain unknown. Free API keys — no card required.
Name, sector, industry, HQ, employees, market cap, source-tagged.
GET /api/v1/companies/CBL
Multi-year statements with per-field source tags and completeness.
GET /api/v1/companies/CBL/financials
P/E, P/B, ROE, ROA, margins, EPS, debt/equity — formulas documented.
GET /api/v1/companies/CBL/metrics/summary
Report PDFs with LLM-ready markdown conversions where available.
GET /api/v1/companies/CBL/filings
Dated press releases and announcements with source links.
GET /api/v1/companies/CBL/news
Create a free key, then:
curl -H "X-API-Key: KEY" https://stockmarketapi.ai/api/v1/companies/CBL
Free tier — instant API key. Built for AI agents.